GVOKE Trademark

Trademark Overview

On Tuesday, September 8, 2020, a trademark application was filed for GVOKE with the United States Patent and Trademark Office. The USPTO has given the GVOKE trademark a serial number of 90165932. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 27, 2024. This trademark is owned by Xeris Pharmaceuticals, Inc.. The GVOKE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases
gvoke

General Information

Serial Number90165932
Word MarkGVOKE
Filing DateTuesday, September 8, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 23, 2021

Trademark Statements

Description of MarkThe mark consists of Two overlapping droplets positioned within a semi-circle, followed by the term "GVOKE".
Goods and ServicesPharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXeris Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60601
Party NameXeris Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60601

Trademark Events

Event DateEvent Description
Friday, September 11, 2020NEW APPLICATION ENTERED
Wednesday, October 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 15, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, January 14, 2021ASSIGNED TO EXAMINER
Tuesday, February 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, January 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 23, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 20, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 12, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, October 20, 2021SOU EXTENSION 1 FILED
Wednesday, October 20, 2021SOU EXTENSION 1 GRANTED
Friday, October 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 22, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 22, 2022SOU EXTENSION 3 FILED
Thursday, September 22, 2022SOU EXTENSION 3 GRANTED
Thursday, April 7, 2022SOU TEAS EXTENSION RECEIVED
Thursday, April 7, 2022SOU EXTENSION 2 FILED
Thursday, April 7, 2022SOU EXTENSION 2 GRANTED
Saturday, April 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, September 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 18, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 20, 2023DIVISIONAL REQUEST RECEIVED
Tuesday, April 18, 2023SOU EXTENSION 4 FILED
Tuesday, April 18, 2023SOU EXTENSION 4 GRANTED
Thursday, April 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 20, 2023TEAS REQUEST TO DIVIDE RECEIVED
Friday, October 20, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 20, 2023SOU EXTENSION 5 FILED
Monday, October 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 30, 2023DIVISIONAL PROCESSING COMPLETE
Monday, October 30, 2023SOU EXTENSION 5 GRANTED
Monday, May 27, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 31, 2023CORRECTED NOA E-MAILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

gvoke metabolic pharmaceutical diabetes diseases treatment products syringes filled vials containing